Analysis of Plasma Levels of Nuclear Factor-κB in Patients With Left-to-right Shunt Congenital Heart Disease Combining Pulmonary Arterial Hypertension
10.3969/j.issn.1000-3614.2016.09.014
- VernacularTitle:左向右分流型先天性心脏病并肺动脉高压患者血浆中核因子-κB的浓度变化及其与肺动脉高压关系的分析
- Author:
Dan ZHU
;
Caiyan GUO
;
Bin PENG
;
Zhenfei FANG
- Publication Type:Journal Article
- Keywords:
Hypertension,pulmonary;
Heart defects,congenital;
Nuclear factor-kappa B
- From:
Chinese Circulation Journal
2016;31(9):885-887
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the impact of nuclear factor-kappa B (NF-κB) in patients with left-to-right shunt congenital heart disease (CHD) combining pulmonary arterial hypertension (PAH) and its clinical signiifcance. Methods: A total of 78 relevant patients were enrolled in this study. According to mean pulmonary artery pressure (mPAP) measured during operation, the patients were divided into 4 groups: Non-PAH group, the patients with mPAP≤25 mmHg,n=20, Mild PAH group, 25 mmHg mPAP≤35 mmHg,n=21, Moderate PAH group, 35 mmHg45 mmHg,n=23. 2 mL pulmonary artery blood was taken from each patient and plasma level of NF-κB was measured by ELISA to study the relationship between NF-κB and mPAP. Results: Pulmonary arterial plasma levels of NF-κB were increased accordingly as in Non-PAH group was (180.59 ± 10.16) ng/L, in Mild PAH group was (572.83 ± 34.80) ng/L, in Moderate PAH group was (980.85 ± 24.95) ng/L and in Severe PAH group was (1 253.4 ±130.8) ng/L, allP<0.01; NF-κB level was positively related to mPAP (r=0.856,P<0.01). Conclusion: Plasma level of NF-κB was involved in the pathological physiology process of left-to-right shunt CHD combining PAH, it couldbe used as one of the references for distinguishing the severity of PAH and for monitoring the dynamic changes of PAH in relevant patients.
